Natural and synthetic iminosugars as carbohydrate processing enzyme inhibitors for cancer therapy

Anti-Cancer Agents in Medicinal Chemistry

Volumn 8, Issue 1, 2008, Pages 77-85

  Wrodnigg, Tanja M ^a,b   Steiner, Andreas J ^a,b   Ueberbacher, Bernhard J ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

Author keywords

Anti cancer; Carbohydrate processing enzyme; Carbohydrates; Iminosugar

Indexed keywords

1 DEOXY N METHYLNOJIRIMYCIN; 1 DEOXYMANNONOJIRIMYCIN; 1,4 DIDEOXY 1,4 IMINOMANNITOL; 2 ACETAMIDO 1,5 IMINO 1,2,5 TRIDEOXY DEXTRO GLUCITOL; 2 ACETAMIDO 2 DEOXY DEXTRO GLUCONO DELTA LACTAM; ANTINEOPLASTIC AGENT; BETA GLUCURONIDASE; BETA N ACETYLHEXOSAMINIDASE; CASTANOSPERMINE; ENZYME INHIBITOR; FLOXURIDINE DERIVATIVE; GD 0039; GLUCARO 1,5 LACTAM; GLYCOLIPID; GLYCOPROTEIN; GLYCOSIDASE; IMINOSUGAR; KIFUNENSINE; MANNITOL; MANNOSIDASE; NAGSTATIN; PROTEOGLYCAN; PYROSTATIN A; PYROSTATIN B; PYRROLIDINE DERIVATIVE; SIASTATIN; SWAINSONINE; UNCLASSIFIED DRUG; OLIGOSACCHARIDE;

CANCER INHIBITION; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DRUG INHIBITION; DRUG STRUCTURE; DRUG WITHDRAWAL; ENZYME ACTIVITY; FATIGUE; HUMAN; IMMUNOMODULATION; KIDNEY CANCER; NAUSEA; NONHUMAN; PHENOTYPE; REVIEW; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; ENZYMOLOGY; METABOLISM; NEOPLASM; SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DESIGN; GLYCOSIDE HYDROLASES; HUMANS; IMINO SUGARS; MOLECULAR STRUCTURE; NEOPLASMS; OLIGOSACCHARIDES;

EID: 39549105156     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152008783330851     Document Type: Review

References (152)

1. a) Martin, O.R.; Compain, P. Curr. Top Med. Chem., 2003, 3, 471-591;
2. b) Lillelund, V.H.; Jensen, H.H.; Liang, X.; Bols, M. Chem. Rev., 2002, 102, 515-553;
3. c) Asano, N.; Nash, R.J.; Molyneux, R.J.; Fleet, G.W.J. Tetrahedron: Asymmetry, 2000, 11, 1645-1680;
4. d) Heightman, T.D.; Vasella, A.T. Angew. Chem. Int. Ed., 1999, 38, 750-770;
5. e) Stiitz, A. E. Iminosugars as Glycosidase Inhibitors, Wiley-VCH: Weinheim, 1999;
6. f) Winchester, B. Biochem. Soc. Trans,. 1992, 20, 699-705.
7. Watson, A.A.; Fleet, G.W.J.; Asano, N.; Molyneux, R.J.; Nash, R.J. Phytochemistry, 2001, 56, 265-295.
8. a) Cipolla, L.; La Ferla, B.; Nicotra, F. Curr. Top Med. Chem., 2003, 3, 485-511;
9. b) Pearson, M.S.M.; Mathé-Allainmat, M.; Fargeas, V.; Lebreton, J. Eur. J. Org. Chem., 2005, 2159-2191;
10. c) Pandit, U.K.; Overkleeft, H.S.; Borer, B.C.; Bieräugel, H. Eur. J. Org. Chem., 1999, 959-968;
11. d) Casiraghi, G.; Zanardi, F.; Rassu, G.; Spanu, P. Chem. Rev., 1995, 95, 1677-1716.
12. Coniff, R.F.; Shapiro, J.A.; Seaton T.B. Arch. Intern Med., 1994, 154, 2442-2448;
13. b) Cheng, X.-M. Annu. Rep. Med. Chem., 1995, 30, 295-317;
14. c) Gaudilliere, B. Annu. Rep. Med. Chem., 1999, 34, 317-338.
15. Häusler, H.; Kawakami, R.P.; Mlaker, E.; Severn, W.B.; Wrodnigg, T.M.; Stütz, A.E. J. Carbohydr. Chem., 2000, 19, 435-449;
16. b) Greimel, P.; Spreitz, J.; Stütz, A.E.; Wrodnigg, T.M. Curr. Top Med. Chem., 2003, 3, 513-523.
17. Nishimura, Y. Curr. Top Med. Chem., 2003, 3, 575-591;
18. b) Goss, P.E.; Baker, M.A.; Carver, J.P.; Dennis, J.W. Clin. Cancer Res., 1995, 1, 935-944.
19. Varki, A.; Cummings, R.D.; Esko, J.; Freeze, H.; Hart, G.W.; Marth, J.. Essentials of Glycobiology, Cold Spring Habor Laboratory Press: Cold Spring Habor, New York, 1999.
20. a) Kato, A.; Kato, N.; Kano, E.; Adachi, I.; Ikeda, K.; Yu, L.; Okamoto, T.; Banba, Y.; Ouchi, H.; Takahata, H.; Asano, N. J. Med. Chem., 2005, 48, 2036-2044;
21. b) Asano, N. Glycobiology, 2003, 13, 93R-104R;
22. c) Winchester, B.; Fleet, G.W.J. J. Carbohydr. Chem., 2000, 19, 471-483.
23. a) Komfeld, R.; Kornfeld, S. Annu. Rev. Biochem., 1985, 54, 631-664;
24. b) Elbein, A.D.; Molyneux, R.J. In Iminosugars as Glycosidase Inhibitors, Stütz, A.E.; Ed.; Wiley-VCH: Weinheim, 1999; pp 216-251.
25. Fidler, I.J. In Clinical Oncology, Abeloff, M.D.; Armitage, J.O.; Lichter, A.S.; Niederhuber, J.E.; Eds.; 2nd edition; Churchill Livingstone: New York, 2000; pp 29-53.
26. Colegate, S.M.; Dorling, P.R.; Huxtable, C.R. Aust. J. Chem., 1979, 32, 2257-2264.
27. a) Dorling, P.R.; Huxtable C.R.; Colegate, S.M. Biochem. J., 1980, 191, 649-651;
28. b) De Gasperi, R.; Daniel, P.F.; Warren, C.D. J. Biol. Chem., 1992, 267, 9706-9712;
29. c) Al Daher, S.; De Gasperi, R.; Daniel, P.F.; Hall, N.; Warren, C.D.; Winchester, B. Biochem. J., 1991, 277, 743-751;
30. d) Cenci di Bello, I.; Fleet, G.; Namgoong, S.K.; Tadano, K.; Winchester, B. Biochem. J., 1989, 259, 855-861.
31. a) Elbein, A.D.; Solf, R.; Dorling, P.R.; Vosbeck, K. Proc. Natl. Acad. Sci., 1981, 78, 7393-7397;
32. b) Tulsiani, D.R.P.; Harris, T.M.; Touster, O. J. Biol. Chem., 1982, 257, 7936-7939;
33. c) Winchester, B.; Al Daher, S.; Carpenter, N.C.; Cenci di Bello, I.; Choi, S.S.; Fairbanks, A.J.; Fleet, G.W.J. Biochem. J., 1993, 290, 743-749.
34. a) Pyne, S.G. Recent Curr. Org. Synth., 2005, 2, 39-57;
35. b) Martin, R.; Murruzzu, C.; Pericas, M.A.; Riera, A. J. Org. Chem., 2005, 70, 2325-2328;
36. c) Nemr, A.E. Tetrahedron, 2000, 56, 8579-8629;
37. d) Michael, J. P. Nat. Prod. Rep., 2004, 21, 625-649;
38. e) Michael, J.P. Nat. Prod. Rep., 2005, 22, 603-626;
39. f) Zhao, H.; Hans, S.; Cheng, X.; Mootoo, D.R. J. Org. Chem., 2001, 66, 1761-1767.
40. Baptista, J.A.; Goss, P.; Nghiem, M.; Krepinsky, J.J.; Baker, M.; Dennis, J.W. Clin. Chem., 1994, 40, 426-430.
41. Goss, P.E.; Baptiste, J.; Fernandes, B.; Baker, M.; Dennis, J.W. Cancer Res., 1994, 54, 1450-1457.
42. Dennis, J.W.; Koch, K.; Yousefi, S.; VanderElst, I. Cancer Res., 1990, 50, 1867-1872.
43. Dennis, J.W. Cancer Res., 1986, 46, 5131-5136.
44. Humphries, M.J.; Olden, K. Pharmacol. Ther., 1989, 44, 85-105.
45. a) Humphries, M.J.; Matsumoto, K.; White, S.L.; Molyneux, R.J.; Olden, K. Cancer Res., 1988, 48, 1410-1415;
46. b) Humphries, M.J.; Matsumoto, K.; White, S.L.; Molyneux, R.J.; Olden, K. Clin. Exp. Metastatsis, 1990, 8, 89-102;
47. c) Das, P. C.; Roberts, J.D.; White, S.L.; Olden, K. Oncol. Res., 1995, 7, 425-433.
48. a) Yagita, M.; Saksela, E. Scand. J. Immunol., 1990, 31, 275-282;
49. b) Colombo, M.P.; Modesti, A.; Parmiani, G.; Forni, G. Cancer Res., 1992, 52, 4853-4857.
50. a) Grzegorzewski, K.; Newton, S.A.; Akiyama, S.K.; Sharrow, S.; Olden, K.; White, S.L. Cancer Commun., 1989, 1, 373-379;
51. b) Breton, P.; Asseffa, A.; Grzegorzewski, K.; Akiyama, S.K.; White, S.L.; Cha,J.K.; Olden, K. Cancer Commun., 1990, 2, 333-338.
52. a) Muchmore, A.; Decker, J.; Shaw, A.; Wingfield, P. Cancer Res., 1990, 50, 6285-6290;
53. b) Lucas, R.; Magez, S.; De Leys, R.; Fransen, L.; Schcerlinck, J.P.; Rampelberg, M.; Sablon, E.; De Baetselier, P. Science, 1994, 263, 814-817.
54. Olden, K.; Breton, P.; Grzegorzewski, K.; Yasuda, Y.; Gause, B.L.; Oredipe, O.A.; Newton, S.A.; White, S.L. Pharm. Ther., 1991, 50, 285-290.
55. Shah, R.; Carver, J.; Marino-Albernas, J.; Tvaroska, I.; Tropper, F.; Dennis, J. Synthesis of analogs of swainsonine for use as antitumor agents. PCT Int. Appl. 1998, WO 9814446, A1 19980409.
56. Bjarnason, G.A.; Walde, D.; Whelan, P.; Chin, J.; Batist, G. 2002 ASCO Annual Meeting, 2002, abstract No 2494.
57. Shaheen, P.E.; Stadler, W.; Elson, P.; Knox, J.; Winquist, E.; Bukowaski, R.M. Invest. New Drugs Online First, 2005, 23, 1-5.
58. a) Dennis, J.W.; White, S.L.; Freer, A.M.; Dime, D. Biochem. Pharmacol., 1993, 46, 1459-1466;
59. b) Pearson, W.H.; Hembre, E.J. Tetrahedron Lett., 2001, 42, 8273-8276;
60. c) Pearson, W.H.; Guo, L. Tetrahedron Lett., 2001, 42, 8267-8271.
61. Palamarczyk, G.; Mitchell, M.; Smitz, P.W.; Fleet, G.W.J.; Elbein, A.D. Arch. Biochem. Biophys., 1985, 243, 35-45.
62. a) Carpenter, N.M.; Fleet, G.W.J.; Cenci di Bello, I.; Winchester, B.; Fellows, L.E.; Nash, R.J. Tetrahedron Lett., 1989, 30, 7261-7264;
63. b) Badorrey, R.; Cativiela, C.; Díaz-de-Villegas, M.D.; Díez, R.; Gálvez, J.A. Tetrahedron Lett., 2004, 45, 719-722.
64. a) Blanco, M.-J.; Sardina, F.J. J. Org. Chem., 1996, 61, 4748-4755 and refs. cited therein;
65. b) Kieß, F.-M.; Poggendorf, P.; Picasso, S.; Jaeger, V. Chem. Commun., 1998, 119-120.
66. Fellows, L.E.; Bell, E.A.; Lynn, D.G.; Pilkiewics, F.; Miura, I.; Nakanishi, K. J. Chem. Soc., Chem., Commun. 1979, 977-978.
67. a) Moremen, K.W. In Carbohydrates in Chemistry and Biology, Ernst, B.; Hart, G.W.; Sinaÿ, P.; Eds.; Part II: Biology of Saccharides, Vol. 3, Chapt. 6; Wiley-VCM Weinheim, 2000; pp 81-117;
68. b) Spiro, R.G. In Carbohydrates in Chemistry and Biology, Ernst, B.; Hart, G. W.; Sinaÿ, P.; Eds.; Part II: Biology of Saccharides, Vol. 3, Chapt. 5; Wiley-VCH: Weinheim, 2000; pp 65-79.
69. a) Boglio, C.; Stahlke, S.; Thorimbert, S.; Malacria, M. Org Lett., 2005, 7, 4851-4854;
70. b) Banwell, M. G.; Ma, X.; Asano, N.; Ikeda, K.; Lambert, J.N. Org. Biomol. Chem., 2003, 1, 2035-2037;
71. c) Knight, J.G.; Tchabanenko, K. Tetrahedron, 2003, 59, 281-286;
72. d) Spreitz, J.; Stütz, A.E.; Wrodnigg, T.M. Carbohydr. Res., 2002, 337, 183-186;
73. e) De Raadt, A.; Stütz, A.E. Tetrahedron Lett., 1992, 33, 189-192 and refs. cited therein;
74. f) Baxter, E.W.; Reitz, A.B. Bioorg. Med. Chem. Lett., 1992, 2, 1419-1422;
75. g) Furneaux, R.H.; Tyler, P.C.; Whitehouse, L.A. Tetrahedron Lett., 1993, 34, 3613-3616;
76. h) Zou, W.; Szarek, W.A. Carbohydr. Res., 1994, 254, 25-33;
77. i) Park, K.H.; Yoon, Y.J.; Lee, S.G. J. Chem. Soc., Perkin Trans. 1, 1994, 2621-2623;
78. j) Johnson, C.R.; Golebiowski, A.; Schoffers, E.; Sundram, H.; Braun, M.P. Synlett, 1995, 313-314;
79. k) Lemaire, M.; Valentin, M.L.; Hecquet, L.; Demuynck, C.; Bolte, J. Tetrahedron: Asymmetry, 1995, 6, 67-70;
80. l) Xu, Y.-M.; Zhou, W.-S. Tetrahedron Lett., 1996, 37, 1461-1462;
81. m) Le Metter, Y.; Poitout, L.; Depezay, J.-C.; Dosbaa, I.; Geoffroy, S.; Foglietti, M.-J. Bioorg. Med. Chem., 1997, 5, 519-533;
82. n) Xu, Y.-M.; Zhou, W.-S. J. Chem. Soc., Perkin Trans. 1, 1997, 741-746;
83. o) Takahashi, S.; Kuzuhara, H. J. Carbohydr. Chem., 1998, 17, 117-128;
84. p) Lee, S.G.; Park, K.H.; Yoon, Y.-J. J. Heterocycl. Chem., 1998, 35, 711-715;
85. q) Asano, K.; Hakogi, T.; Iwama, S.; Katsumura, S. Chem. Commun., 1999, 41-42;
86. r) Yokoyama, H.; Otaya, K.; Kobayashi, H., Miyazawa, M.; Yamaguchi, S.; Hirai, Y. Org. Lett., 2000, 2, 2427-2429;
87. s) Haukaas, M.H.; O'Doherty, G.A. Org. Lett., 2001, 3, 401-404.
88. Van den Elsen, J.M.H.; Kuntz, D.A.; Rose, D.R. EMBO J., 2001, 20, 3008-3017.
89. Ogura, T.; Noguchi, T.; Murai-Takebe, R.; Hosooka, T.; Honma, N.; Kasuga, M. J. Biol. Chem., 2004, 279, 13711-12720.
90. Fiaux, H.; Popowycz, F.; Favre, S.; Schuetz, C.; Vogel, P.; Gerber-Lemaire, S.; Juillerat-Jeanneret, L. J. Med. Chem., 2005, 48, 4237-4246.
91. Kayakiri, H.; Kasahara, C.; Nakamura, K.; Oku, T.; Hashimoto, M. Chem. Pharm. Bull., 1991, 39, 1392-1396.
92. a) Rouden, J.; Hudlicky, T. J. Chem. Soc., Perkin Trans. I: Organic and Bio-Organic Chemistry, 1993, 1095-1097;
93. b) Hudlicky, T.; Rouden, J.; Luna, H.; Allen, S. J. Am. Chem. Soc., 1994, 116, 5099-5107.
94. Hering, K.W.; Karaveg, K.; Moremen, K.W.; Pedrson, W.H. J. Org. Chem., 2005, 70, 9892-9904.
95. a) Hohenschutz, L.D.; Bell, E.A.; Jewess, P.J.; Leworthy, D.P.; Pryce, R.J.; Arnold, E.; Clardy, J. Phytochemistry, 1981, 20, 811-814;
96. b) Nash, R.J.; Fellows, L.E.; Dring, J.V.; Stirton, C.H.; Carter, D.; Hegarty, M.P.; Bell, E.A. Phytochemistry, 1988, 27, 1403-1404.
97. a) Sommai, P.; Marchand, P.; Torsell, S.; Lindstrom, U.M. Tetrahedron, 2003, 59, 1293-1299;
98. b) Kim, J. H.; Seo, W.D.; Lee, J.H.; Lee, B.W.; Park, K.H. Synthesis, 2003, 16, 2473-2478;
99. c) Burgess, K.; Henderson, I. Tetrahedron, 1992, 48, 4045-4066;
100. d) Tyler, P.C.; Winchester, B.G. In Iminosugars as Glycosidase Inhibitors, Stütz, A. E.; Ed.; Wiley-VCH: Weinheim, 1999; pp 125-156;
101. e) Cronin, L.; Murphy, P.V. Org. Lett., 2005, 7, 2691-2693.
102. Pili, R.; Chang, J.; Partis, R.A.; Mueller, R.A.; Chrest, F.J.; Passaniti, A. Cancer Res., 1995, 55, 2920-2926.
103. Ostrander, G.K.; Scribner, N.K.; Rohrschneider, L.R. Cancer Res., 1988, 48, 1091-1094.
104. Humphries, M.J.; Matsumoto, K.; White, S.L.; Olden, K. Cancer Res., 1986, 46, 5212-5222.
105. Spearman, M.A.; Ballon, B.C.; Gerrard J.M.; Greenberg A.H.; Wright J.A. Cancer Lett., 1991, 60, 185-191.
106. Nishiura, T.; Karasuno, T.; Yoshida, H.; Nakao, H.; Ogawa, M.; Horikawa, Y.; Yoshimura, M.; Okajima, Y.; Kanakura, Y.; Kanayama, Y.; Matsuzawa, Y. Blood, 1996, 88, 3546-3554.
107. Ringeard, S.; Harb, J.; Gautier, F.; Menanteau, J.; Meflah, K. J. Cell. Biochem., 1996, 62, 40-49.
108. Trugnan, G.; Rousset, M.; Zweibaum, A. FEBS Lett., 1986, 195, 28-32.
109. Ishiwata, K.; Seki, H.; Sasaki, T.; Ishii, S. I.; Nozaki, T.; Senda, M. Nucl. Med. Biol., 1993, 20, 843-847;
110. b) Kiso, M.; Furui, H.; Ando, K.; Ishida, H.; Hasegawa, A. Bioorg. Med. Chem., 1994, 2, 1295-1308;
111. c) Asano, N.; Oseki, K.; Tomioka, E.; Kizu, H.; Matsui, K. Carbohydr. Res., 1994, 259, 243-255.
112. d) Hettkamp, H.; Legler, G.; Bause, E. Eur. J. Biochem., 1984, 142, 85-90;
113. e) Gross, V.; Tran-Thi, T. A.; Schwarz, R.T.; Elbein, A.D.; Decker, K.; Heinrich, P.C. Biochem. J., 1986, 236, 853-860;
114. f) Romero, P.A.; Herscovics, A. Carbohydr. Res., 1986, 151, 21-28.
115. Hadwiger, A.; Niemann, H.; Kaebisch, A.; Bauer, H.; Tamura, T. EMBO J., 1986, 5, 689-694.
116. Winchester, B.G. Subcell. Biochem., 1996, 27, 191-238;
117. b) Winchester, B.G.; Fleet, G.W.J. Glycobiology, 1992, 2, 199-210.
118. Gradnig, G.; Legler, G.; Stütz, A.E. Carbohydr. Res., 1996, 287, 49-57.
119. Fleet, G.W.J.; Fellows, L.E.; Smith, P.W. Tetrahedron, 1987, 43, 979-990.
120. Schumacher-Wandersleb, M.H.M.G.; Petersen, S.; Peter, M.G. Liebigs Ann. Chem., 1994, 555-561.
121. Kappes,E.; Legler, G. J. Carbohydr. Chem., 1989, 8, 371-388.
122. Kajimoto, T.; Liu, K.K.C.; Pederson, R.L.; Zhong, Z.; Ichikawa, Y.; Porco, J.A.; Wong, C.-H. J. Am. Chem. Soc. 1991, 113, 6187-6169.
123. Fleet, G.W.J; Smith, P.W.; Nash, R.J.; Fellows, L.E.; Parekh, R.J.; Rademacher, T.W. Chem. Lett., 1986, 1051-1054.
124. Woynarowska, B.; Wikiel, H.; Sharma, M.; Carpenter, N.; Fleet, G.W.J.; Bernacki, R.J. Anticancer Res., 1992, 12, 161-166.
125. Aoyagi, T.; Suda, H.; Uotani, K.; Kojima, F.; Aoyama, T.; Horiuchi, T.; Hamada, M.; Takeuchi, T. J. Antibiot., 1992, 45, 1404-1408.
126. Tatsuta, K.; Miura, S.; Ohata, S.; Gunji, H. J. Antibiot., 1995, 48, 286-288;
127. b) Aoyama, T.; Naganawa, H.; Suda, H.; Uotani, K.; Aoyagi, T.; Takeuchi, T. J. Antibiot., 1992, 45, 1557-1558.
128. a) Tatsuta, K.; Miura, S.; Gunji, H. Bull. Chem. Soc. Jpn., 1997, 70, 427-436;
129. b) Tatsuta, K.; Miura, S. Tetrahedron Lett., 1995, 36, 6721-6724.
130. a) Tatsuta, K.; Miura, S.; Ohta, S.; Gunji, H. Tetrahedron Lett., 1995, 36, 1085-1088;
131. b) Terinek, M.; Vasella, A. Helv. Chim. Acta, 2005, 88, 10-22;
132. c) Gessier, F.; Tschamber, T.; Tarnus, C.; Neuburger, M.; Huber, W.; S reith, J. Eur. J. Org. Chem., 2001, 4111-4125;
133. d) Tatsuta, K. Synth. Org. Chem. Jpn., 1997, 55, 970-981;
134. e) Tatsuta, K. Carbohydrate Mimics, 1998, 283-305.
135. a) Imada, C. Antonie van Leeuwenhoek, 2005, 87, 59-63;
136. b) Takeuchi, T.; Aoyanagi, T.; Okami, Y.; Osanawa, H.; Muraoka, Y.; Imada, C.; Aoyama, T. Jpn. Kokai Tokkyo Koho, 1995, 12, pp;
137. c) Aoyama, T.; Kojima, F.; Imada, C.; Muraoka, Y.; Naganawa, H.; Okami, Y.; Takeuchi, T.; Aoyagi, T. J. Enzym Inhib., 1995, 8, 223-232.
138. Tsuruoka, T.; Niwa, T.; Shomura, T.; Matsuno, T.; Itoh, N.; Inoue, S.; Niida, T. Meiji Seika Kenkyu Nenpo, 1973, 13, 80-84.
139. Tsuruoka, T.; Fukutasu, H.; Azetaka, M. Jpn. J. Cancer Res., 1995, 86, 41-47.
140. Fujii, Y.; Iwasa, H.; Hirai, J.; Takahama, Y.; Hasumi, K.; Eriguchi, M. Biomed. Pharmacother., 2000, 54, 85-92.
141. Umezawa, H.; Aoyagi, T.; Komiyama, T.; Morishima, H.; Hamada, M.; Takeuchi, T. J. Antibiot., 1974, 27, 963-969.
142. a) Nishimura, Y.; Wang, W.; Kondo, S.; Aoyagi, T.; Umezawa, H. J. Am. Chem. Soc., 1988, 110, 7249-7256;
143. b) Nishimura, Y.; Kudo, T.; Kondo, S.; Takeuchi, T.; Tsuruoka, T; Fukuyasu, H; Shibahara, S. J. Antibiot., 1994, 47, 101-107;
144. c) Knapp, S.; Zhao, D. Org. Lett., 2000, 2, 4037-4040.
145. Nishimura, Y.; Satoh, T.; Kondo, S.; Takeuchi, T.; Azetaka, M.; Fukuyasu, H.; Inouye, S. J. Antibiot., 1994, 47, 840-842.
146. Satoh, T.; Nishimura, Y.; Kondo, S.; Takeuchi, T. Carbohydr. Res., 1996, 286, 173-178.
147. Johnson, H.A.; Thomas, N.R. Bioorg. Med. Chem. Lett., 2002, 12, 237-241.
148. a) Evans, G.B.; Fumeaux, R.H.; Lewandowicz, A.; Schramm, V.L.; Tyler, P.C. J. Med. Chem., 2003, 46, 3412-3423.
149. b) Schramm, V.L.; Tyler, P.C. Curr. Top Med. Chem., 2003, 3, 525-540.
150. Bantia, S.; Miller, P.J.; Parker, C.D.; Ananth, S.L.; Horn, L.L.; Babu, Y.S.; Sandhu, J.S. Int. Immunopharmacol., 2002, 2, 913-923.
151. Matos, C.R.R.; Lopes, R.S.C.; Claudio, C. Synthesis, 1999, 571-573.
152. Elstein, D.; Hollak, C.; Aerts, J.M.F.G.; Van Weely, S.; Maas, M.; Cox, T.M.; Lachmann, R.H.; Hrebicek, M.; Platt, F.M.; Butters, T.D.; Dwek, R.A.; Zimran, A. J. Inherit. Dis., 2004, 27, 757-766.